Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
- PMID: 20452798
- PMCID: PMC2947589
- DOI: 10.1016/j.ijid.2010.01.006
Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
Abstract
Objectives: To evaluate whether maternal HIV disease severity during pregnancy is associated with an increased likelihood of lower respiratory tract infections (LRTIs) in HIV-exposed, uninfected infants.
Methods: HIV-exposed, uninfected, singleton, term infants enrolled in the NISDI Perinatal Study, with birth weight >2500g were followed from birth until 6 months of age. LRTI diagnoses, hospitalizations, and associated factors were assessed.
Results: Of 547 infants, 103 (18.8%) experienced 116 episodes of LRTI (incidence=0.84 LRTIs/100 child-weeks). Most (81%) episodes were bronchiolitis. Forty-nine (9.0%) infants were hospitalized at least once with an LRTI. There were 53 hospitalizations (45.7%) for 116 LRTI episodes. None of these infants were breastfed. The odds of LRTI in infants whose mothers had CD4% <14 at enrollment were 4.4 times those of infants whose mothers had CD4% ≥29 (p=0.003). The odds of LRTI in infants with a CD4+ count (cells/mm(3)) <750 at hospital discharge were 16.0 times those of infants with CD4+ ≥750 (p=0.002). Maternal CD4+ decline and infant hemoglobin at the 6-12 week visit were associated with infant LRTIs after 6-12 weeks and before 6 months of age.
Conclusions: Acute bronchiolitis is common and frequently severe among HIV-exposed, uninfected infants aged 6 months or less. Lower maternal and infant CD4+ values were associated with a higher risk of infant LRTIs. Further understanding of the immunological mechanisms of severe LRTIs is needed.
Keywords: HIV-exposed; Latin America; infancy; infections.
Copyright © 2010 International Society for Infectious Diseases. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.Pediatrics. 2007 Mar;119(3):e694-704. doi: 10.1542/peds.2006-1856. Epub 2007 Feb 12. Pediatrics. 2007. PMID: 17296782
-
Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.Lancet Child Adolesc Health. 2020 Mar;4(3):220-231. doi: 10.1016/S2352-4642(19)30375-X. Epub 2020 Jan 10. Lancet Child Adolesc Health. 2020. PMID: 31932246 Free PMC article.
-
Factors Associated with Lower Respiratory Tract Infections in HIV-Exposed Uninfected Infants.AIDS Res Hum Retroviruses. 2018 Jun;34(6):527-535. doi: 10.1089/AID.2017.0245. Epub 2018 Apr 23. AIDS Res Hum Retroviruses. 2018. PMID: 29620934 Free PMC article.
-
Infectious disease morbidity and growth among young HIV-exposed uninfected children in Jamaica.Rev Panam Salud Publica. 2016 Dec;40(6):401-409. Rev Panam Salud Publica. 2016. PMID: 28718488
-
The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.Front Immunol. 2018 Mar 2;9:328. doi: 10.3389/fimmu.2018.00328. eCollection 2018. Front Immunol. 2018. PMID: 29552009 Free PMC article. Review.
Cited by
-
Rates of Hospitalization and Infection-Related Hospitalization Among Human Immunodeficiency Virus (HIV)-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016.Clin Infect Dis. 2020 Jul 11;71(2):332-339. doi: 10.1093/cid/ciz820. Clin Infect Dis. 2020. PMID: 31504291 Free PMC article.
-
Altered Natural Killer Cell Function in HIV-Exposed Uninfected Infants.Front Immunol. 2017 Apr 24;8:470. doi: 10.3389/fimmu.2017.00470. eCollection 2017. Front Immunol. 2017. PMID: 28484464 Free PMC article.
-
Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.Pediatr Infect Dis J. 2015 Jan;34(1):27-34. doi: 10.1097/INF.0000000000000484. Pediatr Infect Dis J. 2015. PMID: 24992122 Free PMC article.
-
The Immune System of HIV-Exposed Uninfected Infants.Front Immunol. 2016 Sep 28;7:383. doi: 10.3389/fimmu.2016.00383. eCollection 2016. Front Immunol. 2016. PMID: 27733852 Free PMC article. Review.
-
Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life.mBio. 2022 Oct 26;13(5):e0122922. doi: 10.1128/mbio.01229-22. Epub 2022 Sep 8. mBio. 2022. PMID: 36073815 Free PMC article.
References
-
- Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis. 2002;34:267–76. - PubMed
-
- Fiore S, Newell ML, Trabattoni D, Thorne C, Gray L, Savasi V, et al. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol. 2006;70:143–50. - PubMed
-
- Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. 3′-Azido-3′-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol. 1988;69:299–304. - PubMed
-
- Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis. 2000;181:1590–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials